UniProt ID | PODXL_HUMAN | |
---|---|---|
UniProt AC | O00592 | |
Protein Name | Podocalyxin | |
Gene Name | PODXL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 558 | |
Subcellular Localization |
Apical cell membrane. Cell projection, lamellipodium. Cell projection, filopodium. Cell projection, ruffle. Cell projection, microvillus. Membrane raft. Membrane Single-pass type I membrane protein . In single attached epithelial cells is restricte |
|
Protein Description | Involved in the regulation of both adhesion and cell morphology and cancer progression. Function as an anti-adhesive molecule that maintains an open filtration pathway between neighboring foot processes in the podocyte by charge repulsion. Acts as a pro-adhesive molecule, enhancing the adherence of cells to immobilized ligands, increasing the rate of migration and cell-cell contacts in an integrin-dependent manner. Induces the formation of apical actin-dependent microvilli. Involved in the formation of a preapical plasma membrane subdomain to set up initial epithelial polarization and the apical lumen formation during renal tubulogenesis. Plays a role in cancer development and aggressiveness by inducing cell migration and invasion through its interaction with the actin-binding protein EZR. Affects EZR-dependent signaling events, leading to increased activities of the MAPK and PI3K pathways in cancer cells.. | |
Protein Sequence | MRCALALSALLLLLSTPPLLPSSPSPSPSPSQNATQTTTDSSNKTAPTPASSVTIMATDTAQQSTVPTSKANEILASVKATTLGVSSDSPGTTTLAQQVSGPVNTTVARGGGSGNPTTTIESPKSTKSADTTTVATSTATAKPNTTSSQNGAEDTTNSGGKSSHSVTTDLTSTKAEHLTTPHPTSPLSPRQPTSTHPVATPTSSGHDHLMKISSSSSTVAIPGYTFTSPGMTTTLLETVFHHVSQAGLELLTSGDLPTLASQSAGITASSVISQRTQQTSSQMPASSTAPSSQETVQPTSPATALRTPTLPETMSSSPTAASTTHRYPKTPSPTVAHESNWAKCEDLETQTQSEKQLVLNLTGNTLCAGGASDEKLISLICRAVKATFNPAQDKCGIRLASVPGSQTVVVKEITIHTKLPAKDVYERLKDKWDELKEAGVSDMKLGDQGPPEEAEDRFSMPLIITIVCMASFLLLVAALYGCCHQRLSQRKDQQRLTEELQTVENGYHDNPTLEVMETSSEMQEKKVVSLNGELGDSWIVPLDNLTKDDLDEEEDTHL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
33 | N-linked_Glycosylation | PSPSPSQNATQTTTD CCCCCCCCCCCCCCC | 49.66 | UniProtKB CARBOHYD | |
41 | Phosphorylation | ATQTTTDSSNKTAPT CCCCCCCCCCCCCCC | 33.45 | 24260401 | |
43 | N-linked_Glycosylation | QTTTDSSNKTAPTPA CCCCCCCCCCCCCCC | 50.04 | UniProtKB CARBOHYD | |
45 | Phosphorylation | TTDSSNKTAPTPASS CCCCCCCCCCCCCCE | 41.96 | 20860994 | |
48 | Phosphorylation | SSNKTAPTPASSVTI CCCCCCCCCCCEEEE | 29.08 | 20860994 | |
58 | O-linked_Glycosylation | SSVTIMATDTAQQST CEEEEEEECCCCCCC | 19.26 | OGP | |
60 | Phosphorylation | VTIMATDTAQQSTVP EEEEEECCCCCCCCC | 23.24 | - | |
68 | O-linked_Glycosylation | AQQSTVPTSKANEIL CCCCCCCCCHHHHHH | 38.22 | OGP | |
69 | Phosphorylation | QQSTVPTSKANEILA CCCCCCCCHHHHHHH | 24.57 | 20860994 | |
104 | N-linked_Glycosylation | QQVSGPVNTTVARGG EEECCCCCCEEECCC | 32.92 | UniProtKB CARBOHYD | |
117 | O-linked_Glycosylation | GGGSGNPTTTIESPK CCCCCCCCCEEECCC | 40.34 | 55832239 | |
117 | Phosphorylation | GGGSGNPTTTIESPK CCCCCCCCCEEECCC | 40.34 | - | |
118 | O-linked_Glycosylation | GGSGNPTTTIESPKS CCCCCCCCEEECCCC | 27.34 | 55832243 | |
118 | Phosphorylation | GGSGNPTTTIESPKS CCCCCCCCEEECCCC | 27.34 | - | |
119 | O-linked_Glycosylation | GSGNPTTTIESPKST CCCCCCCEEECCCCC | 25.81 | 55832247 | |
119 | Phosphorylation | GSGNPTTTIESPKST CCCCCCCEEECCCCC | 25.81 | 29396449 | |
122 | Phosphorylation | NPTTTIESPKSTKSA CCCCEEECCCCCCCC | 33.50 | 25159151 | |
125 | O-linked_Glycosylation | TTIESPKSTKSADTT CEEECCCCCCCCCCE | 44.44 | 55832253 | |
125 | Phosphorylation | TTIESPKSTKSADTT CEEECCCCCCCCCCE | 44.44 | - | |
126 | O-linked_Glycosylation | TIESPKSTKSADTTT EEECCCCCCCCCCEE | 34.83 | 55832257 | |
126 | Phosphorylation | TIESPKSTKSADTTT EEECCCCCCCCCCEE | 34.83 | - | |
128 | Phosphorylation | ESPKSTKSADTTTVA ECCCCCCCCCCEEEE | 31.31 | - | |
133 | Phosphorylation | TKSADTTTVATSTAT CCCCCCEEEEEEEEE | 15.38 | 22210691 | |
140 | Phosphorylation | TVATSTATAKPNTTS EEEEEEEECCCCCCC | 34.99 | 22210691 | |
144 | N-linked_Glycosylation | STATAKPNTTSSQNG EEEECCCCCCCCCCC | 56.11 | UniProtKB CARBOHYD | |
155 | Phosphorylation | SQNGAEDTTNSGGKS CCCCCCCCCCCCCCC | 21.27 | 30576142 | |
156 | Phosphorylation | QNGAEDTTNSGGKSS CCCCCCCCCCCCCCC | 39.44 | 30576142 | |
158 | Phosphorylation | GAEDTTNSGGKSSHS CCCCCCCCCCCCCCC | 46.99 | 30576142 | |
162 | O-linked_Glycosylation | TTNSGGKSSHSVTTD CCCCCCCCCCCEEEC | 36.24 | 55832167 | |
163 | O-linked_Glycosylation | TNSGGKSSHSVTTDL CCCCCCCCCCEEECC | 24.22 | 55832173 | |
163 | Phosphorylation | TNSGGKSSHSVTTDL CCCCCCCCCCEEECC | 24.22 | 24114839 | |
165 | O-linked_Glycosylation | SGGKSSHSVTTDLTS CCCCCCCCEEECCCC | 24.09 | OGP | |
165 | Phosphorylation | SGGKSSHSVTTDLTS CCCCCCCCEEECCCC | 24.09 | 24114839 | |
167 | O-linked_Glycosylation | GKSSHSVTTDLTSTK CCCCCCEEECCCCCC | 20.01 | 55832177 | |
168 | O-linked_Glycosylation | KSSHSVTTDLTSTKA CCCCCEEECCCCCCH | 27.19 | 55832183 | |
171 | O-linked_Glycosylation | HSVTTDLTSTKAEHL CCEEECCCCCCHHHC | 36.84 | 55832189 | |
172 | O-linked_Glycosylation | SVTTDLTSTKAEHLT CEEECCCCCCHHHCC | 34.90 | 55832195 | |
173 | O-linked_Glycosylation | VTTDLTSTKAEHLTT EEECCCCCCHHHCCC | 29.10 | 55832199 | |
179 | O-linked_Glycosylation | STKAEHLTTPHPTSP CCCHHHCCCCCCCCC | 39.94 | 55834547 | |
179 | Phosphorylation | STKAEHLTTPHPTSP CCCHHHCCCCCCCCC | 39.94 | - | |
180 | O-linked_Glycosylation | TKAEHLTTPHPTSPL CCHHHCCCCCCCCCC | 26.43 | 55834551 | |
180 | Phosphorylation | TKAEHLTTPHPTSPL CCHHHCCCCCCCCCC | 26.43 | - | |
184 | O-linked_Glycosylation | HLTTPHPTSPLSPRQ HCCCCCCCCCCCCCC | 39.69 | 55834555 | |
184 | Phosphorylation | HLTTPHPTSPLSPRQ HCCCCCCCCCCCCCC | 39.69 | - | |
185 | O-linked_Glycosylation | LTTPHPTSPLSPRQP CCCCCCCCCCCCCCC | 28.44 | 72264153 | |
185 | Phosphorylation | LTTPHPTSPLSPRQP CCCCCCCCCCCCCCC | 28.44 | 25159151 | |
188 | O-linked_Glycosylation | PHPTSPLSPRQPTST CCCCCCCCCCCCCCC | 22.78 | 72335461 | |
188 | Phosphorylation | PHPTSPLSPRQPTST CCCCCCCCCCCCCCC | 22.78 | 25159151 | |
193 | O-linked_Glycosylation | PLSPRQPTSTHPVAT CCCCCCCCCCCCCCC | 37.61 | 50611417 | |
193 | Phosphorylation | PLSPRQPTSTHPVAT CCCCCCCCCCCCCCC | 37.61 | - | |
194 | O-linked_Glycosylation | LSPRQPTSTHPVATP CCCCCCCCCCCCCCC | 31.25 | 50611421 | |
194 | Phosphorylation | LSPRQPTSTHPVATP CCCCCCCCCCCCCCC | 31.25 | - | |
195 | O-linked_Glycosylation | SPRQPTSTHPVATPT CCCCCCCCCCCCCCC | 32.45 | 50611425 | |
195 | Phosphorylation | SPRQPTSTHPVATPT CCCCCCCCCCCCCCC | 32.45 | - | |
200 | O-linked_Glycosylation | TSTHPVATPTSSGHD CCCCCCCCCCCCCCC | 27.60 | 55831827 | |
200 | Phosphorylation | TSTHPVATPTSSGHD CCCCCCCCCCCCCCC | 27.60 | - | |
202 | O-linked_Glycosylation | THPVATPTSSGHDHL CCCCCCCCCCCCCEE | 31.04 | 55831831 | |
202 | Phosphorylation | THPVATPTSSGHDHL CCCCCCCCCCCCCEE | 31.04 | - | |
203 | O-linked_Glycosylation | HPVATPTSSGHDHLM CCCCCCCCCCCCEEE | 35.21 | 55831837 | |
204 | O-linked_Glycosylation | PVATPTSSGHDHLMK CCCCCCCCCCCEEEE | 42.50 | 55831841 | |
232 | O-linked_Glycosylation | TFTSPGMTTTLLETV EEECCCCCHHHHHHH | 23.65 | OGP | |
261 | O-linked_Glycosylation | GDLPTLASQSAGITA CCCCCHHHCCCCCCH | 27.99 | OGP | |
267 | O-linked_Glycosylation | ASQSAGITASSVISQ HHCCCCCCHHHHHHH | 21.40 | OGP | |
267 | Phosphorylation | ASQSAGITASSVISQ HHCCCCCCHHHHHHH | 21.40 | 20068231 | |
269 | O-linked_Glycosylation | QSAGITASSVISQRT CCCCCCHHHHHHHHH | 19.25 | OGP | |
276 | Phosphorylation | SSVISQRTQQTSSQM HHHHHHHHCCCCCCC | 19.86 | 20068231 | |
279 | Phosphorylation | ISQRTQQTSSQMPAS HHHHHCCCCCCCCCC | 22.11 | 20068231 | |
280 | Phosphorylation | SQRTQQTSSQMPASS HHHHCCCCCCCCCCC | 17.78 | 20068231 | |
281 | Phosphorylation | QRTQQTSSQMPASST HHHCCCCCCCCCCCC | 33.61 | 20068231 | |
286 | Phosphorylation | TSSQMPASSTAPSSQ CCCCCCCCCCCCCCC | 23.50 | 20068231 | |
287 | Phosphorylation | SSQMPASSTAPSSQE CCCCCCCCCCCCCCC | 30.60 | 20068231 | |
288 | Phosphorylation | SQMPASSTAPSSQET CCCCCCCCCCCCCCC | 39.84 | 20068231 | |
291 | Phosphorylation | PASSTAPSSQETVQP CCCCCCCCCCCCCCC | 42.04 | 20068231 | |
292 | Phosphorylation | ASSTAPSSQETVQPT CCCCCCCCCCCCCCC | 30.86 | 20068231 | |
295 | O-linked_Glycosylation | TAPSSQETVQPTSPA CCCCCCCCCCCCCCC | 19.46 | OGP | |
295 | Phosphorylation | TAPSSQETVQPTSPA CCCCCCCCCCCCCCC | 19.46 | 20068231 | |
299 | O-linked_Glycosylation | SQETVQPTSPATALR CCCCCCCCCCCHHCC | 30.19 | OGP | |
299 | Phosphorylation | SQETVQPTSPATALR CCCCCCCCCCCHHCC | 30.19 | 20068231 | |
300 | Phosphorylation | QETVQPTSPATALRT CCCCCCCCCCHHCCC | 21.15 | 20068231 | |
303 | Phosphorylation | VQPTSPATALRTPTL CCCCCCCHHCCCCCC | 29.61 | 20068231 | |
307 | O-linked_Glycosylation | SPATALRTPTLPETM CCCHHCCCCCCCCHH | 22.83 | 55824051 | |
309 | O-linked_Glycosylation | ATALRTPTLPETMSS CHHCCCCCCCCHHCC | 55.09 | 55824057 | |
309 | Phosphorylation | ATALRTPTLPETMSS CHHCCCCCCCCHHCC | 55.09 | - | |
315 | O-linked_Glycosylation | PTLPETMSSSPTAAS CCCCCHHCCCCCCCC | 34.77 | 46267497 | |
315 | Phosphorylation | PTLPETMSSSPTAAS CCCCCHHCCCCCCCC | 34.77 | - | |
316 | O-linked_Glycosylation | TLPETMSSSPTAAST CCCCHHCCCCCCCCC | 29.52 | 55824067 | |
316 | Phosphorylation | TLPETMSSSPTAAST CCCCHHCCCCCCCCC | 29.52 | - | |
317 | O-linked_Glycosylation | LPETMSSSPTAASTT CCCHHCCCCCCCCCC | 20.97 | 46267501 | |
317 | Phosphorylation | LPETMSSSPTAASTT CCCHHCCCCCCCCCC | 20.97 | - | |
319 | O-linked_Glycosylation | ETMSSSPTAASTTHR CHHCCCCCCCCCCCC | 36.48 | 55824077 | |
319 | Phosphorylation | ETMSSSPTAASTTHR CHHCCCCCCCCCCCC | 36.48 | - | |
322 | O-linked_Glycosylation | SSSPTAASTTHRYPK CCCCCCCCCCCCCCC | 31.23 | 55824081 | |
322 | Phosphorylation | SSSPTAASTTHRYPK CCCCCCCCCCCCCCC | 31.23 | - | |
323 | O-linked_Glycosylation | SSPTAASTTHRYPKT CCCCCCCCCCCCCCC | 23.15 | 55824085 | |
323 | Phosphorylation | SSPTAASTTHRYPKT CCCCCCCCCCCCCCC | 23.15 | - | |
324 | O-linked_Glycosylation | SPTAASTTHRYPKTP CCCCCCCCCCCCCCC | 11.23 | 55824089 | |
324 | Phosphorylation | SPTAASTTHRYPKTP CCCCCCCCCCCCCCC | 11.23 | - | |
330 | O-linked_Glycosylation | TTHRYPKTPSPTVAH CCCCCCCCCCCCCCC | 25.21 | 55825547 | |
332 | O-linked_Glycosylation | HRYPKTPSPTVAHES CCCCCCCCCCCCCCC | 38.13 | 55825553 | |
332 | Phosphorylation | HRYPKTPSPTVAHES CCCCCCCCCCCCCCC | 38.13 | 24114839 | |
334 | O-linked_Glycosylation | YPKTPSPTVAHESNW CCCCCCCCCCCCCCC | 34.36 | 55825559 | |
334 | Phosphorylation | YPKTPSPTVAHESNW CCCCCCCCCCCCCCC | 34.36 | - | |
339 | O-linked_Glycosylation | SPTVAHESNWAKCED CCCCCCCCCCCCCCC | 28.01 | 45660759 | |
339 | Phosphorylation | SPTVAHESNWAKCED CCCCCCCCCCCCCCC | 28.01 | - | |
344 | S-palmitoylation | HESNWAKCEDLETQT CCCCCCCCCCCCCCC | 3.67 | 29575903 | |
360 | N-linked_Glycosylation | SEKQLVLNLTGNTLC CCEEEEEECCCCCEE | 28.25 | UniProtKB CARBOHYD | |
387 | O-linked_Glycosylation | ICRAVKATFNPAQDK HHHHHHHHCCHHHCC | 20.44 | 55831573 | |
401 | O-linked_Glycosylation | KCGIRLASVPGSQTV CCCEEEEECCCCEEE | 33.18 | 55825351 | |
405 | O-linked_Glycosylation | RLASVPGSQTVVVKE EEEECCCCEEEEEEE | 19.33 | 55825355 | |
407 | O-linked_Glycosylation | ASVPGSQTVVVKEIT EECCCCEEEEEEEEE | 19.57 | 55825359 | |
414 | O-linked_Glycosylation | TVVVKEITIHTKLPA EEEEEEEEEEECCCH | 14.06 | 55826513 | |
417 | O-linked_Glycosylation | VKEITIHTKLPAKDV EEEEEEEECCCHHHH | 30.35 | 55826517 | |
422 | Ubiquitination | IHTKLPAKDVYERLK EEECCCHHHHHHHHH | 45.87 | - | |
425 | Phosphorylation | KLPAKDVYERLKDKW CCCHHHHHHHHHHHH | 12.88 | 28152594 | |
431 | Ubiquitination | VYERLKDKWDELKEA HHHHHHHHHHHHHHC | 55.76 | - | |
436 | 2-Hydroxyisobutyrylation | KDKWDELKEAGVSDM HHHHHHHHHCCCCCC | 43.39 | - | |
441 | Phosphorylation | ELKEAGVSDMKLGDQ HHHHCCCCCCCCCCC | 30.94 | - | |
493 (in isoform 2) | Ubiquitination | - | 33.07 | 21890473 | |
494 (in isoform 2) | Ubiquitination | - | 53.11 | 21890473 | |
502 | Phosphorylation | RLTEELQTVENGYHD HHHHHHHHHHCCCCC | 42.27 | 27251275 | |
507 | Phosphorylation | LQTVENGYHDNPTLE HHHHHCCCCCCCCEE | 19.99 | 27259358 | |
512 | Phosphorylation | NGYHDNPTLEVMETS CCCCCCCCEEEEECC | 41.63 | 23663014 | |
515 (in isoform 2) | Ubiquitination | - | 4.77 | - | |
518 | Phosphorylation | PTLEVMETSSEMQEK CCEEEEECCHHHHHC | 21.32 | 30266825 | |
519 | Phosphorylation | TLEVMETSSEMQEKK CEEEEECCHHHHHCE | 15.82 | 30266825 | |
520 | Phosphorylation | LEVMETSSEMQEKKV EEEEECCHHHHHCEE | 44.50 | 30266825 | |
525 | Ubiquitination | TSSEMQEKKVVSLNG CCHHHHHCEEEEECC | 33.70 | 21906983 | |
526 | Ubiquitination | SSEMQEKKVVSLNGE CHHHHHCEEEEECCC | 47.30 | 21890473 | |
527 (in isoform 1) | Ubiquitination | - | 5.39 | 21890473 | |
528 (in isoform 1) | Ubiquitination | - | 8.06 | 21890473 | |
529 | Phosphorylation | MQEKKVVSLNGELGD HHHCEEEEECCCCCC | 21.07 | 25159151 | |
537 | Phosphorylation | LNGELGDSWIVPLDN ECCCCCCEEEEECHH | 19.53 | 19664994 | |
546 | Phosphorylation | IVPLDNLTKDDLDEE EEECHHCCHHHCCHH | 38.39 | 22777824 | |
547 | Ubiquitination | VPLDNLTKDDLDEEE EECHHCCHHHCCHHH | 53.03 | - | |
556 | Phosphorylation | DLDEEEDTHL----- HCCHHHCCCC----- | 28.49 | 9188463 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PODXL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PODXL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PODXL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NHRF2_HUMAN | SLC9A3R2 | physical | 15642748 | |
NHRF2_HUMAN | SLC9A3R2 | physical | 11457882 | |
HS12A_HUMAN | HSPA12A | physical | 28514442 | |
IMDH1_HUMAN | IMPDH1 | physical | 28514442 | |
HS12B_HUMAN | HSPA12B | physical | 28514442 | |
JIP4_HUMAN | SPAG9 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...